50-12-104: Patient requirements.

A patient is eligible for an experimental treatment if the patient has:

(1) evaluated other treatment options currently approved by the United States food and drug administration;

(2) received a recommendation from the patient's treating health care provider for an experimental treatment;

(3) given informed consent for the use of the experimental treatment; and

(4) received documentation from the treating health care provider that the patient meets the requirements of this section.